The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Predictors of infection in rheumatoid arthritis
Abstract
Objective: Patients with rheumatoid arthritis (RA) have been shown to have an increased susceptibility to the development of infections. The exact causes of this increased risk are unknown, but may relate to immunologic disturbances associated with the disease or to the immunosuppressive effects of agents used in its treatment. This study was undertaken to identify predictors of serious infections among patients with RA. Identification of such factors is the necessary first step in reducing the excess risk of infection in RA. Methods: Members of a population‐based incidence cohort of Rochester, Minnesota residents ages ≥18 years, who had been diagnosed with RA between 1955 and 1994, were followed up longitudinally through their complete medical records until January 1, 2000. We examined potential risk factors for the development of all objectively confirmed (by microbiology or radiology) infections and for infections requiring hospitalization. Potential risk factors included RA severity measures (rheumatoid factor positivity, elevated erythrocyte sedimentation rate, extraarticular manifestations of RA, and functional status), comorbidities (diabetes mellitus, alcoholism, and chronic lung disease), and other risk factors for infection (presence of leukopenia, smoking). Predictors were identified using multivariate time‐dependent Cox proportional hazards modeling. Results: The 609 RA patients in the cohort had a total followup time of 7,729.7 person‐years (mean 12.7 years per patient). A total of 389 patients (64%) had at least 1 infection with objective confirmation, and 290 (48%) had at least 1 infection requiring hospitalization. Increasing age, presence of extraarticular manifestations of RA, leukopenia, and comorbidities (chronic lung disease, alcoholism, organic brain disease, and diabetes mellitus), as well as use of corticosteroids, were strong predictors of infection (P < 0.004) in both univariate and multivariate analyses. Notably, use of disease‐modifying antirheumatic drugs was not associated with increased risk of infection in multivariate analyses, after adjustment for demographic characteristics, comorbidities, and disease‐related variables. Conclusion: We identified a number of strong predictors of infections in a population‐based cohort of patients with RA. These results can be used to prospectively identify high‐risk patients, who may benefit from closer followup and implementation of preventive strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
THERAPEUTIC CRITERIA IN RHEUMATOID ARTHRITIS
STEINBROCKER, O. (1949) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1949.02900430001001 · Cited by 2,877
History of the Rochester Epidemiology Project
Melton, L. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.266 · Cited by 1,443
Doran, M. F., Crowson, C. S., Pond, G. R., O'Fallon, W. M., & Gabriel, S. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10524 · Cited by 1,214
Self-citationInfections in Patients with Diabetes Mellitus
Joshi, N., Caputo, G. M., Weitekamp, M. R., & Karchmer, A. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412507 · Cited by 1,043
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
Stuck, A. E., Minder, C. E., & Frey, F. J. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.6.954 · Cited by 836
The Patient Record in Epidemiology
Kurland, L. T., & Molgaard, C. A. (1981) · Scientific American · doi:10.1038/scientificamerican1081-54 · Cited by 777
Saag, K. G., Koehnke, R., Caldwell, J. R., Brasington, R., Burmeister, L. F., Zimmerman, B., Kohler, J. A., & Furst, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90131-7 · Cited by 540
T cell homeostasis in patients with rheumatoid arthritis
Koetz, K., Bryl, E., Spickschen, K., O'Fallon, W. M., Goronzy, J. J., & Weyand, C. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9203 · Cited by 467
Self-citationRisk factors for septic arthritis in patients with joint disease
Kaandorp, C. J. E., Schaardenburg, D. V., Krijnen, P., Habbema, J. D. F., & Van De Laar, M. A. F. J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381215 · Cited by 438
Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus
Ginzler, E., Diamond, H., Kaplan, D., Weiner, M., Schlesinger, M., & Seleznick, M. (1978) · Arthritis & Rheumatism · doi:10.1002/art.1780210107 · Cited by 281
Perturbation of the T cell repertoire in rheumatoid arthritis
Wagner, U. G., Koetz, K., Weyand, C. M., & Goronzy, J. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14447 · Cited by 278
High Alcohol Intake as a Risk and Prognostic Factor for Community-Acquired Pneumonia
Fernández-Solá, J. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430150137014 · Cited by 199
Fatal Sepsis in a Patient With Rheumatoid Arthritis Treated With Etanercept
Baghai, M., Osmon, D. R., Wolk, D. M., Wold, L. E., Haidukewych, G. J., & Matteson, E. L. (2001) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)62418-x · Cited by 166
Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
Singh, G., Fries, J. F., Williams, C. A., Zatarain, E., Spitz, P. W., & Bloch, D. A. (1991) · PubMed · Cited by 142
van der Veen, M. J., van der Heide, A., Kruize, A. A., & Bijlsma, J. W. J. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.4.224 · Cited by 131
INFECTIOUS COMPLICATIONS OF IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH RHEUMATIC DISEASES
Segal, B. H., & Sneller, M. C. (1997) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70327-6 · Cited by 131
Experience with etanercept in an academic medical center: Are infection rates increased?
Phillips, K., Husni, M. E., Karlson, E. W., & Coblyn, J. S. (2002) · Arthritis Care & Research · doi:10.1002/art1.10243 · Cited by 121
Infections during low-dose methotrexate treatmentin rheumatoid arthritis
Boerbooms, A. M. T., Kerstens, P. J. S. M., van Loenhout, J. W. A., et al. (1995) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(95)80009-3 · Cited by 118
Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community
Farr, B. M., Woodhead, M. A., Macfarlane, J. T., Bartlett, C. L. R., MCCRACKEN, J. S., Wadsworth, J., & Miller, D. L. (2000) · Respiratory Medicine · doi:10.1053/rmed.1999.0743 · Cited by 113
Pneumococcal pneumonia: epidemiology and clinical features.
Marrie, T. J. (1999) · PubMed · Cited by 98
van Albada-Kuipers, G. A., Linthorst, J., Peeters, E. A. J., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310513 · Cited by 46
Cited by
Breedveld, F. C., Weisman, M. H., Kavanaugh, A. F., Cohen, S. B., Pavelka, K., Vollenhoven, R. V., Sharp, J., Perez, J. L., & Spencer‐Green, G. T. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21519 · Cited by 1,785
Dixon, W. G., Watson, K., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21978 · Cited by 751
Rahier, J. F., Ben-Horin, S., Chowers, Y., Conlon, C., De Munter, P., D'Haens, G., Domènech, E., Eliakim, R., Eser, A., Frater, J., et al. (2009) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.02.010 · Cited by 738
Ramiro, S., Gaujoux-Viala, C., Nam, J. L., Smolen, J. S., Buch, M., Gossec, L., van der Heijde, D., Winthrop, K., & Landewé, R. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204575 · Cited by 701
Infections in patients with rheumatoid arthritis treated with biologic agents
Listing, J., Strangfeld, A., Kary, S., Rau, R., von Hinueber, U., Stoyanova‐Scholz, M., Gromnica‐Ihle, E., Antoni, C., Herzer, P., Kekow, J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21386 · Cited by 681
Metadata
- Authors
- Doran, M. F., Crowson, C. S., Pond, G. R., O'Fallon, W. M., & Gabriel, S. E.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2002-09
- Volume
- 46
- Issue
- 9
- Pages
- 2294-2300
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2039110250
- Cited by
- 560
- References
- 25
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.